Back to 13F data
Q1 2026
BIOMARIN PHARMACEUTICAL INC
Original CUSIPs: 09061G101. This page shows current managers, quarterly changes, and primary SEC sources.
Current managers
1
Combined value
$11.7M
Current managers
1
Calculated from each manager’s latest available 13F.
Total shares
206,911
Aggregated at company level with original CUSIP details preserved.
Combined value
$11.7M
Market values are added across managers reporting the same quarter.
Themes
Unclassified
Local mappings are used only for search and classification.
Four-quarter trend
Four-quarter ownership trend
Manager actions by quarter
Current tracked managers holding this company
| Manager | Quarter | Market value | Shares | Portfolio weight | Current-quarter change | Share change | Value change | SEC source |
|---|---|---|---|---|---|---|---|---|
| Bridgewater Associates Ray Dalio / Bridgewater | Q1 2026 | $11,688,402 | 206,911 | 0.05% | Reduced -10.02% | -23,050 | -$1,978,180 | XML 05/15/2026 |
Original CUSIP details
| Manager | Issuer | CUSIP | Security class | Market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| Bridgewater Associates | BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | $11,688,402 | 206,911 | 0.05% | SEC XML |
Quarterly holdings details
| Quarter | Current managers | Combined value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 1 | $12,519,198 | 227,746 | Bridgewater Associates New position |
| Q3 2025 | 1 | $20,346,991 | 375,683 | Bridgewater Associates Increased |
| Q4 2025 | 1 | $13,666,582 | 229,961 | Bridgewater Associates Reduced |
| Q1 2026 | 1 | $11,688,402 | 206,911 | Bridgewater Associates Reduced |
Data source
Holdings facts come from SEC 13F information tables. Tickers, company aliases, and themes are used only for search and normalized display, not as a holdings source.